Opentrons Closes $10M in Seed Funding
Summary
Opentrons, a NYC-based lab automation company, closed a $10M seed funding.The company is using the funds to develop and launch its newest lab robot, OT-2 and new no-code Protocol Designer, expand operations and grow customer adoption.Led by Chiu Chau, Co-Founder and CEO, Will Canine, Co-founder and Chief Product Officer, Opentrons provides biologists with hardware, an open software platform and pipetting robots to automate manual lab work and empower collaborative research for life scientists.OT-2 includes access to a library of verified protocols developed by hundreds of scientists from across the scientific community.Key OT-2 features include: – Protocol Designer, an intuitive, visual design program, allows biologists to create and customize protocols for OT-2 without writing code – Modular additions like temperature and magnet decks that allow users to increase OT-2’s functionality – Novel “tip probe” auto-calibration assistance and electronic pipettes – Access to a library of more than 100 verified protocols and 40 scientific community-developed projects to enable better reproducibility across the scientific community – Open API for integration with tools like Amazon Alexa, microscopes, and computer vision.